5th Annual Operationalize: Expanded Access Programs Summit

The 5th Operationalize: Expanded Access Programs Summit continues to be the premier event for connecting expanded access professionals with their industry peers to share proven strategies for overcoming operational and regulatory barriers, ensuring access to life-changing therapies outside traditional clinical trials. Featuring deep-dive discussions and actionable case studies, the summit addresses global regulatory differences, best practices for transitioning patients to commercial programs, and how to leverage data to support regulatory filings, clinical trials, and therapeutic development. This is the must-attend event for experts aiming to elevate their Expanded Access Programs in 2025 and beyond.

In March, join your peers at this essential gathering, where the brightest minds in Expanded Access from companies like Novartis, Pfizer, BMS, Biogen, Ascendis, and others will converge. This collaborative, non-competitive event is designed to equip you with the knowledge and tools needed to bridge the gap between cutting-edge clinical research and the patients who need it most.